GHUCCTS

News

Share This
  • May 01, 2020

NIH awards $23M to GHUCCTS to support clinical and translational research

WASHINGTON (May 1, 2020) - The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of  the National Institutes of Health.

The competitive renewal represents the third 5-year award for the center, which has secured $89.8 million in research funding over 15-years for its member institutions: Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Affairs Medical Center and Oak Ridge National Laboratory.

Led by principal investigators Joseph Verbalis, MD, from Georgetown University and Thomas Mellman, MD, from Howard University, the mission of GHUCCTS is to advance research and training with excellence, innovation, collaboration, and efficiency while realizing the potential of the unique capacities of its constituent institutions for developing new technologies, promoting ethical clinical and translational research, and engaging the diverse populations of our communities that have been historically underrepresented in clinical research, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

“One of the major missions of GHUCCTS has been to stimulate and support the growth of team science,” says Verbalis, a professor of medicine at Georgetown. “Advances in solving the complex and challenging health problems we face today can be achieved more quickly and efficiently by collaborations among investigators from different scientific disciplines working together on common problems.”

“GHUCCTS was built on a unique model of co-leadership between Georgetown and Howard University, a Historically Black University,” says Mellman, a professor of psychiatry at Howard. “The partnership has influenced prioritizing health disparities and diversity in our training and research missions. Diversity of institutional cultures and of the disciplines represented in our programs has been a founding and enduring strength of GHUCCTS.” 

As one of 60 national CTSA programs, GHUCCTS has transformed research in the greater Washington DC region. Verbalis and Mellman along with faculty members from all of the GHUCCTS institutions and numerous collaborators across the region have achieved impressive goals over the last 10 years, including:

With this new award, GHUCCTS will continue to develop and promote innovative clinical and translational science research to improve the health of the greater Washington DC population.

For more information about GHUCCTS and its programs, visit http://www.georgetownhowardctsa.org/.

Download PDF

Related News

TL1 Scholar Dr. Martha Dee Gay receives Science Writer Fellowship from Georgetown Medicine Magazine

May 15, 2020

2020 Science Writer Fellow Martha Dee Gay is an NIH TL1 post-doctoral scholar and translational scientist at Georgetown University Medical Center in the Division of Gastroenterology. Her article "Life in the NASH Lane" is published in the Spring/Summer 2020 edition of Georgetown Medicine Magazine.

GHUCCTS KL2 Program application deadline extended

May 07, 2020

The GHUCCTS KL2 Program is now accepting applications for the 2019-2020 cycle. Projects that are novel, inter- or multi-disciplinary and collaborative will be favored. The KL2 Scholars will be awarded up to $90,000 salary support and $40,000 project support per year (for up to three years).

NIH awards $23M to GHUCCTS to support clinical and translational research

May 01, 2020

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

Close